CDNA TRANSFECTION FOLLOWED BY THE ISOLATION OF A MCF-7 BREAST CELL-LINE RESISTANT TO TAMOXIFEN IN-VITRO AND IN-VIVO

被引:15
作者
TOI, M [1 ]
HARRIS, AL [1 ]
BICKNELL, R [1 ]
机构
[1] UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOLEC MED,IMPERIAL CANC RES FUND,MOLEC ONCOL LAB,OXFORD OX3 9DU,ENGLAND
关键词
D O I
10.1038/bjc.1993.486
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A tamoxifen resistant cell line (clone 9) has been isolated from the tamoxifen sensitive, hormone responsive MCF-7 breast carcinoma cell line after transfection with mixed cDNA libraries, followed by tamoxifen selection in the presence of oestrogens. Transfection was confirmed by Southern analysis with vector probes. Clone 9 in several-fold more resistant to tamoxifen and other anti-oestrogens than wild type cells when cultured either as a monolayer or as colonies in soft agar but retains oestrogen receptors. Clone 9 was less responsive to 17-beta-oestradiol than were wild type MCF-7. In addition to showing in vitro tamoxifen resistance, clone 9 was also tamoxifen resistant in vivo when xenografted into the nude mouse. Culture medium conditioned by clone 9 cells stimulated quiescent cells of the same clone as well as wild type cells, whereas medium conditioned by wild type MCF-7 was inhibitory to both, suggesting that clone 9 may be secreting an autocrine growth factor. Clone 9 provides a novel model for further investigation of the mechanism of anti-oestrogen resistance that occurs without loss of oestrogen receptors. Preliminary results suggest that an autocrine growth stimulatory mechanism may be one pathway of such resistance.
引用
收藏
页码:1088 / 1096
页数:9
相关论文
共 46 条
[1]  
BEZWODA WR, 1991, CANCER, V68, P867, DOI 10.1002/1097-0142(19910815)68:4<867::AID-CNCR2820680432>3.0.CO
[2]  
2-H
[3]   SELECTION AND CHARACTERIZATION OF A BREAST-CANCER CELL-LINE RESISTANT TO THE ANTIESTROGEN LY-117018 [J].
BRONZERT, DA ;
GREENE, GL ;
LIPPMAN, ME .
ENDOCRINOLOGY, 1985, 117 (04) :1409-1417
[4]   PROGRESSION OF HUMAN-BREAST CANCER-CELLS FROM HORMONE-DEPENDENT TO HORMONE-INDEPENDENT GROWTH BOTH INVITRO AND INVIVO [J].
CLARKE, R ;
BRUNNER, N ;
KATZENELLENBOGEN, BS ;
THOMPSON, EW ;
NORMAN, MJ ;
KOPPI, C ;
PAIK, S ;
LIPPMAN, ME ;
DICKSON, RB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) :3649-3653
[5]   THE PROCESS OF MALIGNANT PROGRESSION IN HUMAN BREAST-CANCER [J].
CLARKE, R ;
DICKSON, RB ;
BRUNNER, N .
ANNALS OF ONCOLOGY, 1990, 1 (06) :401-407
[6]   ANTIESTROGENS INDUCE THE SECRETION OF ACTIVE TRANSFORMING GROWTH-FACTOR-BETA FROM HUMAN FETAL FIBROBLASTS [J].
COLLETTA, AA ;
WAKEFIELD, LM ;
HOWELL, FV ;
VANROOZENDAAL, KEP ;
DANIELPOUR, D ;
EBBS, SR ;
SPORN, MB ;
BAUM, M .
BRITISH JOURNAL OF CANCER, 1990, 62 (03) :405-409
[7]  
COLLINS R, 1992, LANCET, V339, P1
[8]  
COLLINS R, 1992, LANCET, V339, P71
[9]   INSULIN-LIKE GROWTH FACTOR-II OVEREXPRESSION IN MCF-7 CELLS INDUCES PHENOTYPIC CHANGES ASSOCIATED WITH MALIGNANT PROGRESSION [J].
CULLEN, KJ ;
LIPPMAN, ME ;
CHOW, D ;
HILL, S ;
ROSEN, N ;
ZWIEBEL, JA .
MOLECULAR ENDOCRINOLOGY, 1992, 6 (01) :91-100
[10]  
DALY RJ, 1991, CELL GROWTH DIFFER, V2, P457